Brigid C. Flynn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Brigid C. Flynn has a total of 187 co-authors. Here are the top co-authors by number of shared publications:
Jianghua He
University of Kansas Medical Center
11 shared publicationsBrent Kidd
Department of Anesthesiology, University of Kansas Medical Center, Kansas City, KS
5 shared publicationsJaromme Kim
University of Kansas Medical Center
4 shared publications- Andrew Gessouroun
Department of Anesthesiology, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, 66160, Kansas, USA, kumc.edu
3 shared publications Emmanuel Daon
Department of Cardiothoracic Surgery, University of Kansas Medical Center, Kansas City, Kansas
3 shared publicationsKaty Wirtz
Department of Quality Assurance
3 shared publications
Latest Publications
- 5 May 2026
- Published by Elsevier in International Journal of Cardiology
- Vol. 457, 134542
ELSO-score: A practical pre-ECMO risk model for predicting in-hospital mortality in patients receiving VA-ECMO
- 5 May 2026
- Published by Elsevier in International Journal of Cardiology
- Vol. 457, 134542
ELSO-score: A practical pre-ECMO risk model for predicting in-hospital mortality in patients receiving VA-ECMO
- Open Access
- 16 January 2026
- Published by Wiley in Case Reports in Infectious Diseases
- Vol. 2026 (1)
Lethal Case of Bourbon Virus Leading to Shock and ECMO Utilization
We present a lethal case of Bourbon virus infection in a 63‐year‐old Caucasian, diabetic male who was previously in good health. The patient had spent time in the wooded areas of Bourbon County, Kansas, and removed three ticks from his body 5 days prior to presentation. The patient had acute multisystem organ failure requiring multiple inotropes and pressor agents, renal replacement therapy, and venoarterial extracorporeal membrane oxygenation (VA‐ECMO). This report describes the presentation, clinical outcomes, and background on Bourbon virus infection.
- 16 January 2026
- Published by Wiley in Case Reports in Infectious Diseases
- Vol. 2026 (1)
Open AccessLethal Case of Bourbon Virus Leading to Shock and ECMO Utilization
We present a lethal case of Bourbon virus infection in a 63‐year‐old Caucasian, diabetic male who was previously in good health. The patient had spent time in the wooded areas of Bourbon County, Kansas, and removed three ticks from his body 5 days prior to presentation. The patient had acute multisystem organ failure requiring multiple inotropes and pressor agents, renal replacement therapy, and venoarterial extracorporeal membrane oxygenation (VA‐ECMO). This report describes the presentation, clinical outcomes, and background on Bourbon virus infection.
- 4 September 2025
- Published by SAGE Publications in Seminars in Cardiothoracic and Vascular Anesthesia
- Vol. 30 (1) , 21-27
Effect of Preoperative Cannabis Use on Postoperative Pain and Outcomes Following Cardiothoracic Surgery
Cannabis use has grown both recreationally and medicinally in the United States over the past decades, alongside increased legalization and social acceptance. However, there remains little research investigating the effects of preoperative cannabis use on postoperative pain in patients undergoing surgery. We conducted a single-center prospective study in adults undergoing cardiac surgery via sternotomy. Patients seen for preoperative consultation in clinic were asked a standardized survey about cannabis use. Clinical data was collected via chart review. Primary outcomes were morphine equivalents in the first 48 hours postoperatively and Visual Analog Scale (VAS) scores. Secondary outcomes were time to extubation, postoperative nausea/vomiting, ICU length of stay (LOS), reoperation, and in-hospital mortality. The non-cannabis user group had 50 patients, and the cannabis user group had 23 patients. Average morphine equivalents in the first 48 hours were similar between cannabis users and non-users (60.98 vs 59.90; P = 0.93), as were VAS scores at 24 hours (5.52 vs 4.84; P = 0.414) and 48 hours (4.74 vs 3.90; P = 0.23). Average time to extubation (minutes) was nearly identical between cannabis users and non-users (718.41 vs 718.67; P = 0.99). There was also no significant difference in average LOS (days) between cannabis users and non-users (2.91 vs 3.48; P = 0.26). There were no differences in postoperative nausea/vomiting, reoperation, or in-hospital mortality. In patients undergoing cardiac surgery via sternotomy, there was no effect of cannabis use on any outcomes, including morphine equivalents, Visual Analog Scale scores, time to extubation, ICU length of stay, postoperative nausea or vomiting, reoperation, or in-hospital mortality.
- 4 September 2025
- Published by SAGE Publications in Seminars in Cardiothoracic and Vascular Anesthesia
- Vol. 30 (1) , 21-27
Effect of Preoperative Cannabis Use on Postoperative Pain and Outcomes Following Cardiothoracic Surgery
Cannabis use has grown both recreationally and medicinally in the United States over the past decades, alongside increased legalization and social acceptance. However, there remains little research investigating the effects of preoperative cannabis use on postoperative pain in patients undergoing surgery. We conducted a single-center prospective study in adults undergoing cardiac surgery via sternotomy. Patients seen for preoperative consultation in clinic were asked a standardized survey about cannabis use. Clinical data was collected via chart review. Primary outcomes were morphine equivalents in the first 48 hours postoperatively and Visual Analog Scale (VAS) scores. Secondary outcomes were time to extubation, postoperative nausea/vomiting, ICU length of stay (LOS), reoperation, and in-hospital mortality. The non-cannabis user group had 50 patients, and the cannabis user group had 23 patients. Average morphine equivalents in the first 48 hours were similar between cannabis users and non-users (60.98 vs 59.90; P = 0.93), as were VAS scores at 24 hours (5.52 vs 4.84; P = 0.414) and 48 hours (4.74 vs 3.90; P = 0.23). Average time to extubation (minutes) was nearly identical between cannabis users and non-users (718.41 vs 718.67; P = 0.99). There was also no significant difference in average LOS (days) between cannabis users and non-users (2.91 vs 3.48; P = 0.26). There were no differences in postoperative nausea/vomiting, reoperation, or in-hospital mortality. In patients undergoing cardiac surgery via sternotomy, there was no effect of cannabis use on any outcomes, including morphine equivalents, Visual Analog Scale scores, time to extubation, ICU length of stay, postoperative nausea or vomiting, reoperation, or in-hospital mortality.
- Open Access
- 21 July 2025
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 39 (11) , 2948-2952
Characteristics Associated with Mortality in 623 Patients Who Received Recombinant Factor VIIa for Bleeding in Cardiac Surgery
- 21 July 2025
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 39 (11) , 2948-2952
Open AccessCharacteristics Associated with Mortality in 623 Patients Who Received Recombinant Factor VIIa for Bleeding in Cardiac Surgery
- Open Access
- 22 April 2025
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 39 (8) , 2095-2101
Outcomes of Patients Requiring VA-ECMO for Cardiogenic Shock and Evaluation of Programmatic Changes
- 22 April 2025
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 39 (8) , 2095-2101
Open AccessOutcomes of Patients Requiring VA-ECMO for Cardiogenic Shock and Evaluation of Programmatic Changes
- 30 October 2024
- Published by Wiley in JACCP: Journal of the American College of Clinical Pharmacy
- Vol. 7 (11) , 1084-1093
EXaminaTion of cRitical cAre PHArmacist pRoductivity MetricS (EXTRA‐PHARMS): The clinical pharmacist's perspective
Background: Critical care pharmacists are well‐established, valuable members of the intensive care unit interprofessional team with unique skills to perform comprehensive medication management in complex critically ill patients. However, standardized and consequential productivity metrics for critical care pharmacists have not been established.Objective: To characterize the utilization and perception of contemporary critical care pharmacy productivity metrics utilized among individual institutions.Design, Setting, and Participants: An electronic survey was distributed to critical care pharmacist members of the Society of Critical Care Medicine Clinical Pharmacy and Pharmacology Section and the American College of Clinical Pharmacy Critical Care Practice and Research Network.Main Outcomes and Measures: The survey included 23 questions to assess institution demographics, individual respondent demographics, institution practices, and individual respondent perceptions about the value of critical care pharmacist productivity metrics.Results: A total of 204 critical care pharmacists, largely from the United States, responded to the survey between July and November 2022. Institutional metrics captured by more than 50% of the respondents' institutions included order verification rate/number of orders verified (60%), number of clinical interventions (57%), and intravenous to enteral product interchanges (52%). Of these metrics, critical care pharmacists only agreed with the value of the number of clinical interventions, were indifferent to the value of intravenous to oral product interchanges, and disagreed with the value of order verification rate/number of orders verified.Conclusions: Significant discrepancies exist between institutional productivity metric practices and their perceived value and utility among critical care pharmacists.
- 30 October 2024
- Published by Wiley in JACCP: Journal of the American College of Clinical Pharmacy
- Vol. 7 (11) , 1084-1093
EXaminaTion of cRitical cAre PHArmacist pRoductivity MetricS (EXTRA‐PHARMS): The clinical pharmacist's perspective
Background: Critical care pharmacists are well‐established, valuable members of the intensive care unit interprofessional team with unique skills to perform comprehensive medication management in complex critically ill patients. However, standardized and consequential productivity metrics for critical care pharmacists have not been established.Objective: To characterize the utilization and perception of contemporary critical care pharmacy productivity metrics utilized among individual institutions.Design, Setting, and Participants: An electronic survey was distributed to critical care pharmacist members of the Society of Critical Care Medicine Clinical Pharmacy and Pharmacology Section and the American College of Clinical Pharmacy Critical Care Practice and Research Network.Main Outcomes and Measures: The survey included 23 questions to assess institution demographics, individual respondent demographics, institution practices, and individual respondent perceptions about the value of critical care pharmacist productivity metrics.Results: A total of 204 critical care pharmacists, largely from the United States, responded to the survey between July and November 2022. Institutional metrics captured by more than 50% of the respondents' institutions included order verification rate/number of orders verified (60%), number of clinical interventions (57%), and intravenous to enteral product interchanges (52%). Of these metrics, critical care pharmacists only agreed with the value of the number of clinical interventions, were indifferent to the value of intravenous to oral product interchanges, and disagreed with the value of order verification rate/number of orders verified.Conclusions: Significant discrepancies exist between institutional productivity metric practices and their perceived value and utility among critical care pharmacists.
- 18 October 2024
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 38 (12) , 2900-2905
The Year in Cardiothoracic Critical Care: Highlighted Publications From 2023
- 18 October 2024
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 38 (12) , 2900-2905
The Year in Cardiothoracic Critical Care: Highlighted Publications From 2023
- 10 May 2024
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 38 (8) , 1615-1619
On the 2024 Cardiac Surgical Enhanced Recovery After Surgery (ERAS) Joint Consensus Statement
- 10 May 2024
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 38 (8) , 1615-1619
On the 2024 Cardiac Surgical Enhanced Recovery After Surgery (ERAS) Joint Consensus Statement
- Open Access
- 16 April 2024
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 38 (8) , 1753-1759
Sustainability of the Subspecialty of Anesthesiology Critical Care: An Expert Consensus and Review of the Literature
- 16 April 2024
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 38 (8) , 1753-1759
Open AccessSustainability of the Subspecialty of Anesthesiology Critical Care: An Expert Consensus and Review of the Literature
- 10 October 2023
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 38 (1) , 214-220
Postoperative Pulmonary Artery Pulsatility Index Improves Prediction of Right Ventricular Failure After Left Ventricular Assist Device Implantation
- 10 October 2023
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 38 (1) , 214-220
Postoperative Pulmonary Artery Pulsatility Index Improves Prediction of Right Ventricular Failure After Left Ventricular Assist Device Implantation